Capital Fund Management S.A. Bausch Health Companies Inc. Call Options Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	BUY	$25.04 - $30.06 $102,664 - $123,246	4,100 Added 25.15%	20,400 $568,000
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $447,109 - $533,010	16,300 New	16,300 $477,000
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $312,002 - $501,948	-14,600 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $551,160 - $760,320	-36,000 Reduced 71.15%	14,600 $303,000
Q3 2020 Nov 13, 2020	SELL	$14.88 - $20.13 $1.83 Million - $2.48 Million	-123,200 Reduced 70.89%	50,600 $786,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $935,693 - $1.44 Million	70,300 Added 67.92%	173,800 $3.18 Million
Q1 2020 May 13, 2020	SELL	$12.98 - $30.25 $397,188 - $925,650	-30,600 Reduced 22.82%	103,500 $1.6 Million
Q4 2019 Feb 13, 2020	BUY	$18.89 - $31.89 $2.53 Million - $4.28 Million	134,100 New	134,100 $4.01 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.82B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.